BMY - Comprehensive Filing Intelligence
FY 2025•10-K•Filed Feb 11, 2026
5.0/10
Filing Health:CAUTION
Notable concerns that warrant closer review
Executive Summary
Revenue remained flat due to a dynamic mix of growth in newer products and significant generic erosion in legacy products.. Operating expenses decreased, largely driven by lower impairment charges and cost savings from a strategic productivity initiative, leading to improved EPS.. The company has significant operating lease obligations totaling $2.028 billion, with $271 million due in 2026. These leases are for facilities and vehicles, with terms ranging from one to 14 years.. Total revenues were relatively flat year-over-year.
Top Concerns
- !The company is actively managing its portfolio, with strong growth in the 'Growth Portfolio' offset by significant declines in 'Legacy Portfolio' products due to patent expirations and generic competition.
- !Significant intangible asset impairment charges ($949M in 2025).
- !Heavy reliance on estimates for revenue adjustments (GTN, rebates, returns).
- !The company has significant operating lease obligations totaling $2.028 billion, with $271 million due in 2026. These leases are for facilities and vehicles, with terms ranging from one to 14 years.
- !Regulatory Pricing Pressure (IRA and others) (high)
Top Positives
- +Revenue remained flat due to a dynamic mix of growth in newer products and significant generic erosion in legacy products.
- +Operating expenses decreased, largely driven by lower impairment charges and cost savings from a strategic productivity initiative, leading to improved EPS.
- +The company is actively managing its portfolio, with strong growth in the 'Growth Portfolio' offset by significant declines in 'Legacy Portfolio' products due to patent expirations and generic competition.